List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Hereditary Angioedema Treatment Product Introduction
1.2 Global Hereditary Angioedema Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Hereditary Angioedema Treatment Sales in US$ Million for the Year 2017-2028
1.2.2 Global Hereditary Angioedema Treatment Sales in Volume for the Year 2017-2028
1.3 United States Hereditary Angioedema Treatment Outlook 2017 VS 2022 VS 2028
1.3.1 United States Hereditary Angioedema Treatment Sales in US$ Million for the Year 2017-2028
1.3.2 United States Hereditary Angioedema Treatment Sales in Volume for the Year 2017-2028
1.4 Hereditary Angioedema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Hereditary Angioedema Treatment in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Hereditary Angioedema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Hereditary Angioedema Treatment Market Dynamics
1.5.1 Hereditary Angioedema Treatment Industry Trends
1.5.2 Hereditary Angioedema Treatment Market Drivers
1.5.3 Hereditary Angioedema Treatment Market Challenges
1.5.4 Hereditary Angioedema Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Hereditary Angioedema Treatment Market Segment by Type
2.1.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.1.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.1.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.1.4 Others (Conventional Drugs, Pipeline Drugs)
2.2 Global Hereditary Angioedema Treatment Market Size by Type
2.2.1 Global Hereditary Angioedema Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Hereditary Angioedema Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Hereditary Angioedema Treatment Market Size by Type
2.3.1 United States Hereditary Angioedema Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Hereditary Angioedema Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Hereditary Angioedema Treatment Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Others (online pharmacies, mail pharmacies)
3.2 Global Hereditary Angioedema Treatment Market Size by Application
3.2.1 Global Hereditary Angioedema Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Hereditary Angioedema Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Hereditary Angioedema Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Hereditary Angioedema Treatment Market Size by Application
3.3.1 United States Hereditary Angioedema Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Hereditary Angioedema Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Hereditary Angioedema Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Hereditary Angioedema Treatment Competitor Landscape by Company
4.1 Global Hereditary Angioedema Treatment Market Size by Company
4.1.1 Top Global Hereditary Angioedema Treatment Manufacturers Ranked by Revenue (2021)
4.1.2 Global Hereditary Angioedema Treatment Revenue by Manufacturer (2017-2022)
4.1.3 Global Hereditary Angioedema Treatment Sales by Manufacturer (2017-2022)
4.1.4 Global Hereditary Angioedema Treatment Price by Manufacturer (2017-2022)
4.2 Global Hereditary Angioedema Treatment Concentration Ratio (CR)
4.2.1 Hereditary Angioedema Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hereditary Angioedema Treatment in 2021
4.2.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Type
4.3.1 Global Hereditary Angioedema Treatment Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Hereditary Angioedema Treatment Product Type
4.3.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Hereditary Angioedema Treatment Market Size by Company
4.5.1 Top Hereditary Angioedema Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Hereditary Angioedema Treatment Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Hereditary Angioedema Treatment Sales by Players (2020, 2021 & 2022)
5 Global Hereditary Angioedema Treatment Market Size by Region
5.1 Global Hereditary Angioedema Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Hereditary Angioedema Treatment Market Size in Volume by Region (2017-2028)
5.2.1 Global Hereditary Angioedema Treatment Sales in Volume by Region: 2017-2022
5.2.2 Global Hereditary Angioedema Treatment Sales in Volume Forecast by Region (2023-2028)
5.3 Global Hereditary Angioedema Treatment Market Size in Value by Region (2017-2028)
5.3.1 Global Hereditary Angioedema Treatment Sales in Value by Region: 2017-2022
5.3.2 Global Hereditary Angioedema Treatment Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Hereditary Angioedema Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CSL
7.1.1 CSL Corporation Information
7.1.2 CSL Description and Business Overview
7.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL Hereditary Angioedema Treatment Products Offered
7.1.5 CSL Recent Development
7.2 Pharming Group
7.2.1 Pharming Group Corporation Information
7.2.2 Pharming Group Description and Business Overview
7.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
7.2.5 Pharming Group Recent Development
7.3 Shire plc (Takeda Pharmaceutical Company Limited)
7.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
7.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
7.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
7.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Corporation Information
7.4.2 Ionis Pharmaceuticals Description and Business Overview
7.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.4.5 Ionis Pharmaceuticals Recent Development
7.5 Attune Pharmaceuticals
7.5.1 Attune Pharmaceuticals Corporation Information
7.5.2 Attune Pharmaceuticals Description and Business Overview
7.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.5.5 Attune Pharmaceuticals Recent Development
7.6 BioCryst Pharmaceuticals
7.6.1 BioCryst Pharmaceuticals Corporation Information
7.6.2 BioCryst Pharmaceuticals Description and Business Overview
7.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.6.5 BioCryst Pharmaceuticals Recent Development
7.7 KalVista Pharmaceuticals
7.7.1 KalVista Pharmaceuticals Corporation Information
7.7.2 KalVista Pharmaceuticals Description and Business Overview
7.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.7.5 KalVista Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Hereditary Angioedema Treatment Industry Chain Analysis
8.2 Hereditary Angioedema Treatment Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Hereditary Angioedema Treatment Distributors
8.3 Hereditary Angioedema Treatment Production Mode & Process
8.4 Hereditary Angioedema Treatment Sales and Marketing
8.4.1 Hereditary Angioedema Treatment Sales Channels
8.4.2 Hereditary Angioedema Treatment Distributors
8.5 Hereditary Angioedema Treatment Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
